Antioxidants (Feb 2021)

Oxidative Stress Status in COVID-19 Patients Hospitalized in Intensive Care Unit for Severe Pneumonia. A Pilot Study

  • Joël Pincemail,
  • Etienne Cavalier,
  • Corinne Charlier,
  • Jean-Paul Cheramy–Bien,
  • Eric Brevers,
  • Audrey Courtois,
  • Marjorie Fadeur,
  • Smail Meziane,
  • Caroline Le Goff,
  • Benoît Misset,
  • Adelin Albert,
  • Jean-Olivier Defraigne,
  • Anne-Françoise Rousseau

DOI
https://doi.org/10.3390/antiox10020257
Journal volume & issue
Vol. 10, no. 2
p. 257

Abstract

Read online

Background: A key role of oxidative stress has been highlighted in the pathogenesis of COVID-19. However, little has been said about oxidative stress status (OSS) of COVID-19 patients hospitalized in intensive care unit (ICU). Material and Methods: Biomarkers of the systemic OSS included antioxidants (9 assays), trace elements (3 assays), inflammation markers (4 assays) and oxidative damage to lipids (3 assays). Results: Blood samples were drawn after 9 (7–11) and 41 (39–43) days of ICU stay, respectively in 3 and 6 patients. Vitamin C, thiol proteins, reduced glutathione, γ-tocopherol, β-carotene and PAOT® score were significantly decreased compared to laboratory reference values. Selenium concentration was at the limit of the lower reference value. By contrast, the copper/zinc ratio (as a source of oxidative stress) was higher than reference values in 55% of patients while copper was significantly correlated with lipid peroxides (r = 0.95, p < 0.001). Inflammatory biomarkers (C-reactive protein and myeloperoxidase) were significantly increased when compared to normals. Conclusions: The systemic OSS was strongly altered in critically ill COVID-19 patients as evidenced by increased lipid peroxidation but also by deficits in some antioxidants (vitamin C, glutathione, thiol proteins) and trace elements (selenium).

Keywords